Article
Analysis of common polymorphisms within NR1I2 and NR1I3 genes and tacrolimus dose-adjusted concentration in stable kidney transplant recipients.
Pharmacogenetics and genomics - 1 Oct 2017
Kurzawski Mateusz, Malinowski Damian, Dziewanowski Krzysztof, Droździk Marek
Abstract excerpt
OBJECTIVES: Several genetic factors were identified to be responsible for interidividual variability in tacrolimus (TAC) pharmacokinetics, with the predominant role of CYP3A5 and CYP3A4 polymorphisms. In this study, genetic variants of NR1I2 and NR1I3 nuclear receptors (responsible for the regulation of drug-metabolizing enzymes and transporters at the transcriptional level) were evaluated for their potential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
